	YEAR	CONDITION	COUNT
0	2017.0	Breast Cancer	41
1	2017.0	Lymphoma	23
2	2017.0	Leukemia	18
3	2017.0	Prostate Cancer	18
4	2017.0	Pancreatic Cancer	11
5	2017.0	Acute Lymphoblastic Leukemia	9
6	2017.0	Myelodysplastic Syndromes	9
7	2017.0	Melanoma	8
8	2017.0	Neuroblastoma	8
9	2017.0	Acute Myeloid Leukemia	7
10	2017.0	Cancer	7
11	2017.0	Chronic Lymphocytic Leukemia	7
12	2017.0	Head and Neck Cancer	7
13	2017.0	Sarcoma	7
14	2017.0	Brain and Central Nervous System Tumors	6
15	2017.0	Esophageal Cancer	6
16	2017.0	Glioblastoma Multiforme	6
17	2017.0	Myelodysplastic Syndrome	6
18	2017.0	Colorectal Cancer	5
19	2017.0	Liver Cancer	5
20	2017.0	Lung Cancer	5
21	2017.0	Multiple Myeloma	5
22	2017.0	Pancreas Cancer	5
23	2017.0	Cervical Cancer	4
24	2017.0	Gastric Cancer	4
25	2017.0	Glioma	4
26	2017.0	Hodgkin Lymphoma	4
27	2017.0	Metastatic Breast Cancer	4
28	2017.0	Metastatic Colorectal Cancer	4
29	2017.0	Non-Hodgkin Lymphoma	4
30	2017.0	Non-Hodgkin's Lymphoma	4
31	2017.0	Non-small Cell Lung Cancer	4
32	2017.0	Ovarian Cancer	4
33	2017.0	Pain	4
34	2017.0	Rhabdomyosarcoma	4
35	2017.0	Small Lymphocytic Lymphoma	4
36	2017.0	Acute Leukemia	3
37	2017.0	Acute Myelogenous Leukemia	3
38	2017.0	Acute Myeloid Leukemia (AML)	3
39	2017.0	Anaplastic Astrocytoma	3
40	2017.0	Brain Cancer	3
41	2017.0	Chronic Myelogenous Leukemia	3
42	2017.0	Diffuse Intrinsic Pontine Glioma	3
43	2017.0	Diffuse Large B Cell Lymphoma	3
44	2017.0	Follicular Lymphoma	3
45	2017.0	Germ Cell Tumors	3
46	2017.0	Hodgkin's Lymphoma	3
47	2017.0	Lymphoblastic Lymphoma	3
48	2017.0	Malignant Melanoma	3
49	2017.0	Medulloblastoma	3
50	2017.0	Myelodysplasia	3
51	2017.0	Neoplasms	3
52	2017.0	Neuroendocrine Tumors	3
53	2017.0	Prostatic Neoplasms	3
54	2017.0	Retinoblastoma	3
55	2017.0	Solid Tumor	3
56	2017.0	Stage IV Breast Cancer	3
57	2017.0	T-Cell Lymphoma	3
58	2017.0	Acute Myelocytic Leukemia	2
59	2017.0	Adenocarcinoma of the Lung	2
60	2017.0	Bladder Cancer	2
61	2017.0	Brain Metastasis	2
62	2017.0	Brain Neoplasms	2
63	2017.0	Brain Tumor, Recurrent	2
64	2017.0	Breast Neoplasms	2
65	2017.0	Burkitt's Lymphoma	2
66	2017.0	Cancer of Head and Neck	2
67	2017.0	Carcinoma, Non-Small-Cell Lung	2
68	2017.0	Carcinoma, Squamous Cell of Head and Neck	2
69	2017.0	Castration-resistant Prostate Cancer	2
70	2017.0	Central Nervous System Embryonal Tumor	2
71	2017.0	Cervical Intraepithelial Neoplasia (CIN 2/3)	2
72	2017.0	Chronic Myeloproliferative Disorders	2
73	2017.0	Colon Cancer	2
74	2017.0	Fallopian Tube Cancer	2
75	2017.0	Germ Cell Tumor	2
76	2017.0	Glioblastoma	2
77	2017.0	Graft Versus Host Disease	2
78	2017.0	HPV16+	2
79	2017.0	Hodgkin's Disease	2
80	2017.0	Juvenile Myelomonocytic Leukemia	2
81	2017.0	Kidney Cancer	2
82	2017.0	Leukemia, Myelocytic, Acute	2
83	2017.0	Lymphangioleiomyomatosis	2
84	2017.0	Lymphoma, B-Cell	2
85	2017.0	Lymphoma, Follicular	2
86	2017.0	MDS	2
87	2017.0	Malignant Gliomas	2
88	2017.0	Marginal Zone B-Cell Lymphoma	2
89	2017.0	Metastatic Cancer	2
90	2017.0	Metastatic Melanoma	2
91	2017.0	Multiple Myeloma and Plasma Cell Neoplasm	2
92	2017.0	Myelodysplastic Syndrome (MDS)	2
93	2017.0	Myelofibrosis	2
94	2017.0	Neuroectodermal Tumors, Primitive	2
95	2017.0	Neurofibromatosis Type 2	2
96	2017.0	Pancreatic Adenocarcinoma	2
97	2017.0	Pancreatic Neoplasms	2
98	2017.0	Rectal Cancer	2
99	2017.0	Recurrent Breast Cancer	2
100	2017.0	Recurrent Glioblastoma	2
101	2017.0	Recurrent Non-small Cell Lung Cancer	2
102	2017.0	Recurrent Ovarian Cancer	2
103	2017.0	Severe Aplastic Anemia	2
104	2017.0	Soft Tissue Sarcoma	2
105	2017.0	Squamous Cell Carcinoma	2
106	2017.0	Squamous Cell Carcinoma of the Head and Neck	2
107	2017.0	Stage IV Prostate Cancer	2
108	2017.0	Triple Negative Breast Cancer	2
109	2017.0	Tuberous Sclerosis Complex	2
110	2017.0	Urothelial Cancer	2
111	2017.0	Wilms Tumor	2
112	2017.0	 Adverse Effect	1
113	2017.0	 Breast Prosthesis, Infection or Inflammation	1
114	2017.0	AML	1
115	2017.0	Acquired Immunodeficiency Syndrome	1
116	2017.0	Acute Granulocytic Leukemia	1
117	2017.0	Acute Leukemias	1
118	2017.0	Acute Lymphoblastic Leukemia in Complete Remission	1
119	2017.0	Acute Lymphocytic Leukemia (ALL)	1
120	2017.0	Acute Lymphoid Leukemia	1
121	2017.0	Acute Non-Lymphocytic Leukemia	1
122	2017.0	Adenocarcinoma	1
123	2017.0	Adenocarcinoma of the Gastroesophageal Junction	1
124	2017.0	Adenocarcinoma of the Prostate	1
125	2017.0	Adenocarcinoma of the Rectum	1
126	2017.0	Adenoidcystic Carcinoma	1
127	2017.0	Adult Brain Tumor	1
128	2017.0	Adult Diffuse Large B-Cell Lymphoma	1
129	2017.0	Adult Giant Cell Glioblastoma	1
130	2017.0	Adult Glioblastoma	1
131	2017.0	Adult Gliosarcoma	1
132	2017.0	Advanced HER2-positive Breast Cancer	1
133	2017.0	Advanced Non-small Cell Lung Cancer	1
134	2017.0	Advanced Non-squamous Non-Small Cell Lung Cancer	1
135	2017.0	Advanced Solid Tumors, Non-small Cell Lung Cancer	1
136	2017.0	Allogeneic Transplant	1
137	2017.0	Ameloblastoma	1
138	2017.0	Anal Cancer	1
139	2017.0	Anastomotic Leak	1
140	2017.0	Anesthesia	1
141	2017.0	Arthralgia	1
142	2017.0	Asymptomatic or Low Symptomatic Brain Metastasis in Breast Cancer	1
143	2017.0	Atherosclerosis	1
144	2017.0	Atypical Ductal Breast Hyperplasia	1
145	2017.0	Atypical Teratoid/Rhabdoid Tumor (AT/RT)	1
146	2017.0	Autoimmune Diseases	1
147	2017.0	B-Cell Lymphoma Originating in the CNS	1
148	2017.0	B-cell Adult Acute Lymphoblastic Leukemia	1
149	2017.0	BRAF Gene Mutation	1
150	2017.0	BRCA1 Gene Mutation	1
151	2017.0	BRCA2 Gene Mutation	1
152	2017.0	Basal Cell Carcinoma	1
153	2017.0	Bladder Carcinoma	1
154	2017.0	Bleeding	1
155	2017.0	Bone Metastases	1
156	2017.0	Bone Mineral Density Quantitative Trait Locus 3	1
157	2017.0	Borderline Resectable Pancreatic Cancer	1
158	2017.0	Brain Metastases	1
159	2017.0	Brain Metastases From HER2 and Breast Cancer	1
160	2017.0	Brain Stem Glioma	1
161	2017.0	Brain Tumor	1
162	2017.0	Brain Tumor - Metastatic	1
163	2017.0	Brainstem Glioma	1
164	2017.0	Breast Cancer Prevention	1
165	2017.0	Breast Cancer Stage IV	1
166	2017.0	Breast Neoplasm	1
167	2017.0	CNS Tumors	1
168	2017.0	COPD	1
169	2017.0	Cancer Malignancies	1
170	2017.0	Cancer of Nasopharynx	1
171	2017.0	Cancer of the Breast	1
172	2017.0	Cancer of the Pancreas	1
173	2017.0	Cancer-related Cognitive Difficulties	1
174	2017.0	Carcinoid Tumors	1
175	2017.0	Carcinoma of Larynx	1
176	2017.0	Carcinoma of the Breast	1
177	2017.0	Carcinoma, Squamous	1
178	2017.0	Cardiovascular Disease	1
179	2017.0	Castrate Resistant Prostate Cancer	1
180	2017.0	Castration Resistant Prostate Cancer	1
181	2017.0	Chediak Higashi Syndrome	1
182	2017.0	Chemo Brain	1
183	2017.0	Chemo Fog	1
184	2017.0	Chemobrain	1
185	2017.0	Chemotherapy Naive Prostate Cancer	1
186	2017.0	Chemotherapy-related Cognitive Impairment	1
187	2017.0	Childhood Germ Cell Tumor	1
188	2017.0	Childhood Lymphoma	1
189	2017.0	Childhood Solid Tumor	1
190	2017.0	Cholangiocarcinoma	1
191	2017.0	Choroid Plexus Tumors	1
192	2017.0	Chronic Granulomatous Disease	1
193	2017.0	Chronic Lymphocytic Leukemia (CLL)	1
194	2017.0	Chronic Myelocytic Leukemia	1
195	2017.0	Chronic Myeloid Leukemia	1
196	2017.0	Chronic Rhinosinusitis Without Nasal Polyps	1
197	2017.0	Colonic Cancer	1
198	2017.0	Colorectal Cancer Metastatic	1
199	2017.0	Complications	1
200	2017.0	Cutaneous Lymphoma	1
201	2017.0	Cutaneous T Cell Lymphoma	1
202	2017.0	Cystadenoma, Mucinous	1
203	2017.0	Deficiency of Vitamin D3	1
204	2017.0	Dementia	1
205	2017.0	Depression	1
206	2017.0	Desmoid Tumor	1
207	2017.0	Desmoplastic Small Round Cell Tumor	1
208	2017.0	Diamond Blackfan Anemia	1
209	2017.0	Diffuse Large B-Cell Lymphoma	1
210	2017.0	Diffuse Large B-cell Lymphoma	1
211	2017.0	Diffuse Large Cell Lymphoma Relapsed/Refractory	1
212	2017.0	Diffuse, Large B-Cell, Lymphoma	1
213	2017.0	Disseminated Neuroblastoma	1
214	2017.0	Ductal Breast Carcinoma in Situ	1
215	2017.0	Ductal Carcinoma in Situ	1
216	2017.0	Dyskeratosis Congenita	1
217	2017.0	EWINGS SARCOMA	1
218	2017.0	Early Invasive Cervical Squamous Cell Carcinoma	1
219	2017.0	Early Stage Breast Cancer	1
220	2017.0	Endometrial Cancer	1
221	2017.0	Epitheliod Malignant Pleural Mesothelioma	1
222	2017.0	Erectile Dysfunction	1
223	2017.0	Esophageal Neoplasms	1
224	2017.0	Ewing Sarcoma	1
225	2017.0	Ewing's Family Tumors	1
226	2017.0	Extensive Stage Small Cell Lung Cancer	1
227	2017.0	Extrahepatic Bile Duct Cancer	1
228	2017.0	Fallopian Tube Carcinoma	1
229	2017.0	Fanconi Anemia	1
230	2017.0	Fatigue Related to Cancer Treatment	1
231	2017.0	Fibrillary Astrocytoma of Brain	1
232	2017.0	Follicular Thyroid Cancer Lymph Node Metastasis	1
233	2017.0	Functional Disability	1
234	2017.0	Gallbladder Cancer	1
235	2017.0	Gastrointestinal Cancer	1
236	2017.0	Gastrointestinal Cancers	1
237	2017.0	Gastrointestinal Stromal Tumor	1
238	2017.0	Gene Mutation	1
239	2017.0	Genitourinary Cancer	1
240	2017.0	Genitourinary Cancers	1
241	2017.0	Germline Mutation Carrier	1
242	2017.0	Glanzmann Thrombasthenia	1
243	2017.0	Glial Cell Tumors	1
244	2017.0	Glioblastoma - Category	1
245	2017.0	Glioblastoma Multiforme of Brain	1
246	2017.0	Glioma - Recurrent Grade II	1
247	2017.0	Glioma of Brainstem	1
248	2017.0	Gliomatosis Cerebri	1
249	2017.0	Gliosarcoma	1
250	2017.0	Graft-Versus-Host Disease	1
251	2017.0	Graves' Disease	1
252	2017.0	Gynecologic Cancer	1
253	2017.0	Gynecologic Cancers	1
254	2017.0	HER-2 Positive Breast Cancer	1
255	2017.0	HER2 Positive Untreated Metastatic Breast Cancer	1
256	2017.0	HPV Positive Oropharyngeal Squamous Cell Carcinoma	1
257	2017.0	Head and Neck Cancers	1
258	2017.0	Heart Disease	1
259	2017.0	Hematologic Malignancies	1
260	2017.0	Hematological Malignancies	1
261	2017.0	Hematopoietic Stem Cells	1
262	2017.0	Hemoglobinuria, Paroxysmal Nocturnal (PNH)	1
263	2017.0	Hemophagocytic Lymphohistiocytosis	1
264	2017.0	Hepatoblastoma	1
265	2017.0	Hepatocellular Carcinoma	1
266	2017.0	Her 2 Positive Breast Cancer	1
267	2017.0	High Grade Malignant Neoplasm	1
268	2017.0	High Risk Prostate Cancer	1
269	2017.0	High Risk WHO Grade II Glioma	1
270	2017.0	High-grade Meningioma	1
271	2017.0	Histiocytic Sarcoma (HS)	1
272	2017.0	Histiocytoses Erdheim-chester Disease	1
273	2017.0	Hodgkin Disease	1
274	2017.0	Hodgkin or Non-Hodgkin Lymphoma	1
275	2017.0	Hot Flashes	1
276	2017.0	Hot Flushes	1
277	2017.0	Human Epidermal Growth Factor 2 Negative Carcinoma of Breast	1
278	2017.0	Hurler Syndrome	1
279	2017.0	Hypopharyngeal Cancer	1
280	2017.0	Inflammatory Breast Cancer	1
281	2017.0	Inflammatory Breast Carcinoma	1
282	2017.0	Intraocular Lymphoma	1
283	2017.0	Invasive Breast Cancer	1
284	2017.0	Invasive Breast Cancer (Stage I-III)	1
285	2017.0	Irradiation	1
286	2017.0	JMML	1
287	2017.0	Juvenile Myelomonocytic Leukemia (JMML)	1
288	2017.0	Kaposiform Hemangioendothelioma (KHE)	1
289	2017.0	Kasabach-Merritt Syndrome	1
290	2017.0	Knee Pain Chronic	1
291	2017.0	Langerhans Cell Histiocytosis (LCH)	1
292	2017.0	Larynx	1
293	2017.0	Leukemia, Acute Lymphocytic (ALL)	1
294	2017.0	Leukemia, Acute Myelogenous	1
295	2017.0	Leukemia, Lymphocytic, Acute	1
296	2017.0	Leukemia, Lymphocytic, Chronic	1
297	2017.0	Leukemia, Myeloid, Acute(AML)	1
298	2017.0	Leukemia, Myeloid, Chronic	1
299	2017.0	Leukemia, Myeloid, Chronic(CML)	1
300	2017.0	Leukemias	1
301	2017.0	Leukocyte Adhesion Deficiency	1
302	2017.0	Limited Stage Small Cell Lung Cancer	1
303	2017.0	Lobular Breast Carcinoma in Situ	1
304	2017.0	Lobular Carcinoma	1
305	2017.0	Lobular Carcinoma in Situ	1
306	2017.0	Localized Pancreas Cancer	1
307	2017.0	Lymphoblastic Lymphoma in Complete Remission	1
308	2017.0	Lymphoma, Large B-Cell, Diffuse	1
309	2017.0	Lymphoma, Non-Hodgkin	1
310	2017.0	Lymphoma, Non-Hodgkin (NHL)	1
311	2017.0	Lymphomas	1
312	2017.0	Lymphoplasmacytic Lymphoma	1
313	2017.0	Lynch Syndrome	1
314	2017.0	MTOR	1
315	2017.0	Malignancies	1
316	2017.0	Malignant Glioma	1
317	2017.0	Malignant Lymphoma - Lymphoplasmacytic	1
318	2017.0	Malignant Neoplasm of Female Breast	1
319	2017.0	Mantle Cell Lymphoma	1
320	2017.0	Mantle Cell Lymphoma Recurrent	1
321	2017.0	Mantle-Cell Lymphoma	1
322	2017.0	Mature B-Cell Lymphoma	1
323	2017.0	Medulloblastoma, Childhood	1
324	2017.0	Metastatic Castration-resistant Prostate Cancer	1
325	2017.0	Metastatic Hormone-sensitive Prostate Cancer	1
326	2017.0	Metastatic Invasive Breast Cancer	1
327	2017.0	Metastatic Medullary Thyroid Cancer	1
328	2017.0	Metastatic Osteosarcoma	1
329	2017.0	Metastatic Pancreatic Cancer	1
330	2017.0	Metastatic Pheochromocytoma	1
331	2017.0	Metastatic Renal Cell Carcinoma	1
332	2017.0	Metastatic Sarcoma	1
333	2017.0	Metastatic Triple Negative Breast Cancer	1
334	2017.0	Mixed Oligodendroglioma-Astrocytoma	1
335	2017.0	Mixed Phenotype Acute Leukemia in Complete Remission	1
336	2017.0	Myeloid Hematological Malignancies	1
337	2017.0	Myeloma	1
338	2017.0	NF1	1
339	2017.0	Nausea	1
340	2017.0	Neoplasms Pancreatic	1
341	2017.0	Neoplasms, Esophageal	1
342	2017.0	Neoplasms, Head and Neck	1
343	2017.0	Neurofibromatosis	1
344	2017.0	Neuropathic Pain	1
345	2017.0	Neuropathy	1
346	2017.0	Nicotine Dependence	1
347	2017.0	Non Small Cell Lung Cancer	1
348	2017.0	Non-Melanoma Skin Cancers	1
349	2017.0	Non-Small Cell Lung Cancer	1
350	2017.0	Non-Small Cell Lung Cancer (NSCLC)	1
351	2017.0	Non-hodgkin's Lymphoma	1
352	2017.0	Non-metastatic Pancreas Cancer	1
353	2017.0	Nonneoplastic Condition	1
354	2017.0	Ocular Melanoma	1
355	2017.0	Oropharyngeal Cancer	1
356	2017.0	Oropharyngeal Neoplasms	1
357	2017.0	Osteoarthritis	1
358	2017.0	Osteoporosis	1
359	2017.0	Osteosarcoma	1
360	2017.0	Pancreatic Cancer Metastatic	1
361	2017.0	Pancreatic Cyst	1
362	2017.0	Pancreatic Ductal Carcinoma	1
363	2017.0	Pancreatic Intraductal Papillary-Mucinous Neoplasm	1
364	2017.0	Papillary Carcinoma of Thyroid Metastatic to Regional Lymph Node	1
365	2017.0	Papillary Mucinous Cystadenoma, Borderline Malignancy	1
366	2017.0	Paraganglioma	1
367	2017.0	Pediatric Cancer	1
368	2017.0	Pediatric Progressive Low-grade Gliomas	1
369	2017.0	Pediatric Recurrent Progressive Low-grade Gliomas	1
370	2017.0	Peripheral Nervous System Diseases	1
371	2017.0	Peripheral T-cell Lymphoma	1
372	2017.0	Peritoneal Cancer	1
373	2017.0	Peutz-Jeghers Syndrome	1
374	2017.0	Pheochromocytoma	1
375	2017.0	Pilomyxoid Astrocytoma	1
376	2017.0	Pituitary Adenomas	1
377	2017.0	Plasma Cell Leukemia	1
378	2017.0	Plasma Cell Neoplasm	1
379	2017.0	Platinum Sensitive Ovarian Cancer	1
380	2017.0	Plexiform Neurofibromas	1
381	2017.0	Post Transplant Lymphoproliferative Disorder	1
382	2017.0	Primary Malignant Brain Neoplasms	1
383	2017.0	Primary Mediastinal (Thymic) Large B-cell Lymphoma	1
384	2017.0	Primary Peritoneal Cancer	1
385	2017.0	Primary Peritoneal Carcinoma	1
386	2017.0	Progressive Vestibular Schwannomas	1
387	2017.0	Progressive or Refractory High-Grade Glioma	1
388	2017.0	Prolactinomas	1
389	2017.0	Prolymphocytic Leukemia	1
390	2017.0	Prostate Adenocarcinoma	1
391	2017.0	Radiation Necrosis	1
392	2017.0	Radiation Pneumonitis	1
393	2017.0	Recurrent Adult Brain Tumor	1
394	2017.0	Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia	1
395	2017.0	Recurrent Childhood B-Lymphoblastic Lymphoma	1
396	2017.0	Recurrent Glioma	1
397	2017.0	Recurrent Melanoma	1
398	2017.0	Recurrent Nasopharynx Carcinoma	1
399	2017.0	Recurrent Neuroblastoma	1
400	2017.0	Recurrent Osteosarcoma	1
401	2017.0	Recurrent Prostate Cancer	1
402	2017.0	Recurrent Small Cell Lung Cancer	1
403	2017.0	Recurrent/Post-Chemotherapy WHO Grade II Glioma	1
404	2017.0	Recurrent/Refractory CNS	1
405	2017.0	Refractory Acute Myeloid Leukemia	1
406	2017.0	Refractory T-Cell Lymphoma	1
407	2017.0	Relapsed Acute Myeloid Leukemia	1
408	2017.0	Relapsed Neuroblastoma	1
409	2017.0	Relapsed T-Cell Lymphoma	1
410	2017.0	Relapsed/Refractory Acute Myeloid Leukemia	1
411	2017.0	Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas	1
412	2017.0	Renal Tumors	1
413	2017.0	Resectable Pancreatic Cancer	1
414	2017.0	Resectable Pancreatic Cancers	1
415	2017.0	Rheumatoid Arthritis	1
416	2017.0	SOLID TUMORS	1
417	2017.0	Sarcoma, Ewing	1
418	2017.0	Sarcoma, Myeloid	1
419	2017.0	Severe Congenital Neutropenia	1
420	2017.0	Shwachman Diamond Syndrome	1
421	2017.0	Small Cell Lung Cancer	1
422	2017.0	Soft Tissue Metastases	1
423	2017.0	Solid Organ Malignancies	1
424	2017.0	Solid Tumors	1
425	2017.0	Squamous Cell Carcinoma of the Skin	1
426	2017.0	Stage I-III Colon Cancer	1
427	2017.0	Stage IA Breast Cancer	1
428	2017.0	Stage IB Breast Cancer	1
429	2017.0	Stage II Breast Cancer	1
430	2017.0	Stage II Childhood Hodgkin Lymphoma	1
431	2017.0	Stage II Rectal Cancer	1
432	2017.0	Stage IIA Prostate Cancer	1
433	2017.0	Stage IIB Prostate Cancer	1
434	2017.0	Stage III Childhood Hodgkin Lymphoma	1
435	2017.0	Stage III Prostate Cancer	1
436	2017.0	Stage III Rectal Cancer	1
437	2017.0	Stage IIIA Breast Cancer	1
438	2017.0	Stage IIIA Melanoma	1
439	2017.0	Stage IIIA Non-small Cell Lung Cancer	1
440	2017.0	Stage IIIB Breast Cancer	1
441	2017.0	Stage IIIB Melanoma	1
442	2017.0	Stage IIIB Non-small Cell Lung Cancer	1
443	2017.0	Stage IIIC Breast Cancer	1
444	2017.0	Stage IIIC Melanoma	1
445	2017.0	Stage IV Childhood Hodgkin Lymphoma	1
446	2017.0	Stage IV Colon Cancer With Resectable Liver Metastases	1
447	2017.0	Stage IV Melanoma	1
448	2017.0	Stage IV Non-small Cell Lung Cancer	1
449	2017.0	Stage, Colon Cancer	1
450	2017.0	Stomach Cancer	1
451	2017.0	Stroke	1
452	2017.0	Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET)	1
453	2017.0	Systemic Inflammatory Process	1
454	2017.0	T-cell Adult Acute Lymphoblastic Leukemia	1
455	2017.0	TSC1	1
456	2017.0	TSC2	1
457	2017.0	Teratoma	1
458	2017.0	Testicular Neoplasms	1
459	2017.0	Thalassemia	1
460	2017.0	Thoracic Cancers	1
461	2017.0	Thrombocytopenia	1
462	2017.0	Thyroid Cancer	1
463	2017.0	Triple-negative Breast Cancer	1
464	2017.0	Tufted Angioma	1
465	2017.0	UV Ray Skin Damage	1
466	2017.0	Unresectable Locally Advanced Invasive Breast Cancer	1
467	2017.0	Unspecified Adult Solid Tumor, Protocol Specific	1
468	2017.0	Uterine Cervix Cancer	1
469	2017.0	Venous Thrombosis	1
470	2017.0	Vestibular Schwannomas	1
471	2017.0	Vomiting	1
472	2017.0	Waldenstrom Macroglobulinemia	1
473	2017.0	Waldenstrom's Macroglobulinemia	1
474	2017.0	Wiskott-Aldrich Syndrome	1
475	2018.0	Breast Cancer	19
476	2018.0	Prostate Cancer	13
477	2018.0	Lymphoma	12
478	2018.0	Leukemia	8
479	2018.0	Neuroblastoma	8
480	2018.0	Acute Lymphoblastic Leukemia	7
481	2018.0	Chronic Lymphocytic Leukemia	7
482	2018.0	Acute Myeloid Leukemia	6
483	2018.0	Pancreatic Cancer	5
484	2018.0	Melanoma	4
485	2018.0	Myelodysplastic Syndrome	4
486	2018.0	Pancreas Cancer	4
487	2018.0	Rhabdomyosarcoma	4
488	2018.0	Sarcoma	4
489	2018.0	Small Lymphocytic Lymphoma	4
490	2018.0	Acute Myeloid Leukemia (AML)	3
491	2018.0	Cancer	3
492	2018.0	Chronic Myelogenous Leukemia	3
493	2018.0	Colorectal Cancer	3
494	2018.0	Diffuse Large B Cell Lymphoma	3
495	2018.0	Esophageal Cancer	3
496	2018.0	Glioblastoma Multiforme	3
497	2018.0	Glioma	3
498	2018.0	Head and Neck Cancer	3
499	2018.0	Hodgkin's Lymphoma	3
500	2018.0	Lymphoblastic Lymphoma	3
501	2018.0	Medulloblastoma	3
502	2018.0	Metastatic Breast Cancer	3
503	2018.0	Metastatic Colorectal Cancer	3
504	2018.0	Myelodysplasia	3
505	2018.0	Non-Hodgkin Lymphoma	3
506	2018.0	Ovarian Cancer	3
507	2018.0	Retinoblastoma	3
508	2018.0	Acute Leukemia	2
509	2018.0	Acute Myelocytic Leukemia	2
510	2018.0	Anaplastic Astrocytoma	2
511	2018.0	Brain Neoplasms	2
512	2018.0	Brain Tumor, Recurrent	2
513	2018.0	Brain and Central Nervous System Tumors	2
514	2018.0	Breast Neoplasms	2
515	2018.0	Burkitt's Lymphoma	2
516	2018.0	Carcinoma, Squamous Cell of Head and Neck	2
517	2018.0	Cervical Cancer	2
518	2018.0	Colon Cancer	2
519	2018.0	Fallopian Tube Cancer	2
520	2018.0	Follicular Lymphoma	2
521	2018.0	Germ Cell Tumor	2
522	2018.0	Graft Versus Host Disease	2
523	2018.0	Hodgkin Lymphoma	2
524	2018.0	Lymphoma, B-Cell	2
525	2018.0	Lymphoma, Follicular	2
526	2018.0	Malignant Melanoma	2
527	2018.0	Marginal Zone B-Cell Lymphoma	2
528	2018.0	Metastatic Melanoma	2
529	2018.0	Multiple Myeloma	2
530	2018.0	Myelodysplastic Syndromes	2
531	2018.0	Myelofibrosis	2
532	2018.0	Neuroectodermal Tumors, Primitive	2
533	2018.0	Non-Hodgkin's Lymphoma	2
534	2018.0	Pancreatic Adenocarcinoma	2
535	2018.0	Pancreatic Neoplasms	2
536	2018.0	Prostatic Neoplasms	2
537	2018.0	Rectal Cancer	2
538	2018.0	Recurrent Breast Cancer	2
539	2018.0	Recurrent Glioblastoma	2
540	2018.0	Severe Aplastic Anemia	2
541	2018.0	Soft Tissue Sarcoma	2
542	2018.0	Squamous Cell Carcinoma	2
543	2018.0	T-Cell Lymphoma	2
544	2018.0	Wilms Tumor	2
545	2018.0	Acute Granulocytic Leukemia	1
546	2018.0	Acute Leukemias	1
547	2018.0	Acute Lymphoblastic Leukemia in Complete Remission	1
548	2018.0	Acute Lymphocytic Leukemia (ALL)	1
549	2018.0	Acute Myelogenous Leukemia	1
550	2018.0	Acute Non-Lymphocytic Leukemia	1
551	2018.0	Adenocarcinoma	1
552	2018.0	Adenocarcinoma of the Gastroesophageal Junction	1
553	2018.0	Adenocarcinoma of the Lung	1
554	2018.0	Adenocarcinoma of the Rectum	1
555	2018.0	Adult Brain Tumor	1
556	2018.0	Adult Diffuse Large B-Cell Lymphoma	1
557	2018.0	Advanced HER2-positive Breast Cancer	1
558	2018.0	Allogeneic Transplant	1
559	2018.0	Ameloblastoma	1
560	2018.0	Anal Cancer	1
561	2018.0	Anastomotic Leak	1
562	2018.0	Asymptomatic or Low Symptomatic Brain Metastasis in Breast Cancer	1
563	2018.0	Atherosclerosis	1
564	2018.0	Atypical Teratoid/Rhabdoid Tumor (AT/RT)	1
565	2018.0	B-Cell Lymphoma Originating in the CNS	1
566	2018.0	B-cell Adult Acute Lymphoblastic Leukemia	1
567	2018.0	BRAF Gene Mutation	1
568	2018.0	Bladder Cancer	1
569	2018.0	Bladder Carcinoma	1
570	2018.0	Bleeding	1
571	2018.0	Borderline Resectable Pancreatic Cancer	1
572	2018.0	Brain Metastases From HER2 and Breast Cancer	1
573	2018.0	Brain Metastasis	1
574	2018.0	Brain Stem Glioma	1
575	2018.0	Brain Tumor - Metastatic	1
576	2018.0	Brainstem Glioma	1
577	2018.0	Breast Cancer Prevention	1
578	2018.0	Breast Cancer Stage IV	1
579	2018.0	CNS Tumors	1
580	2018.0	COPD	1
581	2018.0	Cancer Malignancies	1
582	2018.0	Cancer of Nasopharynx	1
583	2018.0	Cancer of the Pancreas	1
584	2018.0	Cancer-related Cognitive Difficulties	1
585	2018.0	Carcinoma of Larynx	1
586	2018.0	Carcinoma of the Breast	1
587	2018.0	Carcinoma, Non-Small-Cell Lung	1
588	2018.0	Carcinoma, Squamous	1
589	2018.0	Castrate Resistant Prostate Cancer	1
590	2018.0	Castration-resistant Prostate Cancer	1
591	2018.0	Chediak Higashi Syndrome	1
592	2018.0	Chemotherapy Naive Prostate Cancer	1
593	2018.0	Childhood Lymphoma	1
594	2018.0	Childhood Solid Tumor	1
595	2018.0	Cholangiocarcinoma	1
596	2018.0	Chronic Granulomatous Disease	1
597	2018.0	Chronic Lymphocytic Leukemia (CLL)	1
598	2018.0	Chronic Myelocytic Leukemia	1
599	2018.0	Cystadenoma, Mucinous	1
600	2018.0	Deficiency of Vitamin D3	1
601	2018.0	Dementia	1
602	2018.0	Depression	1
603	2018.0	Desmoplastic Small Round Cell Tumor	1
604	2018.0	Diamond Blackfan Anemia	1
605	2018.0	Diffuse Intrinsic Pontine Glioma	1
606	2018.0	Diffuse Large B-Cell Lymphoma	1
607	2018.0	Diffuse Large B-cell Lymphoma	1
608	2018.0	Diffuse Large Cell Lymphoma Relapsed/Refractory	1
609	2018.0	Diffuse, Large B-Cell, Lymphoma	1
610	2018.0	Disseminated Neuroblastoma	1
611	2018.0	Ductal Carcinoma in Situ	1
612	2018.0	Dyskeratosis Congenita	1
613	2018.0	EWINGS SARCOMA	1
614	2018.0	Early Invasive Cervical Squamous Cell Carcinoma	1
615	2018.0	Early Stage Breast Cancer	1
616	2018.0	Endometrial Cancer	1
617	2018.0	Epitheliod Malignant Pleural Mesothelioma	1
618	2018.0	Ewing Sarcoma	1
619	2018.0	Ewing's Family Tumors	1
620	2018.0	Extensive Stage Small Cell Lung Cancer	1
621	2018.0	Fallopian Tube Carcinoma	1
622	2018.0	Fanconi Anemia	1
623	2018.0	Fatigue Related to Cancer Treatment	1
624	2018.0	Fibrillary Astrocytoma of Brain	1
625	2018.0	Functional Disability	1
626	2018.0	Gastric Cancer	1
627	2018.0	Gastrointestinal Stromal Tumor	1
628	2018.0	Gene Mutation	1
629	2018.0	Germ Cell Tumors	1
630	2018.0	Germline Mutation Carrier	1
631	2018.0	Glanzmann Thrombasthenia	1
632	2018.0	Glial Cell Tumors	1
633	2018.0	Glioblastoma	1
634	2018.0	Glioblastoma Multiforme of Brain	1
635	2018.0	Glioma - Recurrent Grade II	1
636	2018.0	Glioma of Brainstem	1
637	2018.0	Gliomatosis Cerebri	1
638	2018.0	Gliosarcoma	1
639	2018.0	Graft-Versus-Host Disease	1
640	2018.0	Graves' Disease	1
641	2018.0	HER-2 Positive Breast Cancer	1
642	2018.0	HER2 Positive Untreated Metastatic Breast Cancer	1
643	2018.0	HPV Positive Oropharyngeal Squamous Cell Carcinoma	1
644	2018.0	Heart Disease	1
645	2018.0	Hematologic Malignancies	1
646	2018.0	Hematopoietic Stem Cells	1
647	2018.0	Hemophagocytic Lymphohistiocytosis	1
648	2018.0	Hepatoblastoma	1
649	2018.0	Her 2 Positive Breast Cancer	1
650	2018.0	High Risk Prostate Cancer	1
651	2018.0	Histiocytic Sarcoma (HS)	1
652	2018.0	Histiocytoses Erdheim-chester Disease	1
653	2018.0	Hodgkin Disease	1
654	2018.0	Hodgkin or Non-Hodgkin Lymphoma	1
655	2018.0	Hodgkin's Disease	1
656	2018.0	Human Epidermal Growth Factor 2 Negative Carcinoma of Breast	1
657	2018.0	Hurler Syndrome	1
658	2018.0	Hypopharyngeal Cancer	1
659	2018.0	Inflammatory Breast Cancer	1
660	2018.0	Inflammatory Breast Carcinoma	1
661	2018.0	Invasive Breast Cancer	1
662	2018.0	Invasive Breast Cancer (Stage I-III)	1
663	2018.0	Juvenile Myelomonocytic Leukemia	1
664	2018.0	Kaposiform Hemangioendothelioma (KHE)	1
665	2018.0	Kasabach-Merritt Syndrome	1
666	2018.0	Langerhans Cell Histiocytosis (LCH)	1
667	2018.0	Leukemia, Acute Myelogenous	1
668	2018.0	Leukocyte Adhesion Deficiency	1
669	2018.0	Limited Stage Small Cell Lung Cancer	1
670	2018.0	Liver Cancer	1
671	2018.0	Lobular Carcinoma	1
672	2018.0	Lobular Carcinoma in Situ	1
673	2018.0	Lung Cancer	1
674	2018.0	Lymphangioleiomyomatosis	1
675	2018.0	Lymphoblastic Lymphoma in Complete Remission	1
676	2018.0	Lymphoma, Large B-Cell, Diffuse	1
677	2018.0	Lymphoma, Non-Hodgkin	1
678	2018.0	Lymphoplasmacytic Lymphoma	1
679	2018.0	Lynch Syndrome	1
680	2018.0	MTOR	1
681	2018.0	Malignant Glioma	1
682	2018.0	Malignant Gliomas	1
683	2018.0	Malignant Lymphoma - Lymphoplasmacytic	1
684	2018.0	Mantle Cell Lymphoma	1
685	2018.0	Mantle Cell Lymphoma Recurrent	1
686	2018.0	Mantle-Cell Lymphoma	1
687	2018.0	Mature B-Cell Lymphoma	1
688	2018.0	Medulloblastoma, Childhood	1
689	2018.0	Metastatic Castration-resistant Prostate Cancer	1
690	2018.0	Metastatic Hormone-sensitive Prostate Cancer	1
691	2018.0	Metastatic Invasive Breast Cancer	1
692	2018.0	Metastatic Osteosarcoma	1
693	2018.0	Metastatic Pheochromocytoma	1
694	2018.0	Metastatic Renal Cell Carcinoma	1
695	2018.0	Metastatic Sarcoma	1
696	2018.0	Metastatic Triple Negative Breast Cancer	1
697	2018.0	Mixed Oligodendroglioma-Astrocytoma	1
698	2018.0	Mixed Phenotype Acute Leukemia in Complete Remission	1
699	2018.0	Myelodysplastic Syndrome (MDS)	1
700	2018.0	Myeloid Hematological Malignancies	1
701	2018.0	Neoplasms	1
702	2018.0	Neoplasms Pancreatic	1
703	2018.0	Neoplasms, Esophageal	1
704	2018.0	Nicotine Dependence	1
705	2018.0	Non Small Cell Lung Cancer	1
706	2018.0	Non-Melanoma Skin Cancers	1
707	2018.0	Non-Small Cell Lung Cancer (NSCLC)	1
708	2018.0	Nonneoplastic Condition	1
709	2018.0	Oropharyngeal Cancer	1
710	2018.0	Oropharyngeal Neoplasms	1
711	2018.0	Osteosarcoma	1
712	2018.0	Pancreatic Cancer Metastatic	1
713	2018.0	Pancreatic Cyst	1
714	2018.0	Pancreatic Ductal Carcinoma	1
715	2018.0	Pancreatic Intraductal Papillary-Mucinous Neoplasm	1
716	2018.0	Papillary Mucinous Cystadenoma, Borderline Malignancy	1
717	2018.0	Paraganglioma	1
718	2018.0	Pediatric Progressive Low-grade Gliomas	1
719	2018.0	Pediatric Recurrent Progressive Low-grade Gliomas	1
720	2018.0	Peripheral Nervous System Diseases	1
721	2018.0	Peripheral T-cell Lymphoma	1
722	2018.0	Peritoneal Cancer	1
723	2018.0	Peutz-Jeghers Syndrome	1
724	2018.0	Pheochromocytoma	1
725	2018.0	Pilomyxoid Astrocytoma	1
726	2018.0	Plasma Cell Leukemia	1
727	2018.0	Platinum Sensitive Ovarian Cancer	1
728	2018.0	Post Transplant Lymphoproliferative Disorder	1
729	2018.0	Primary Malignant Brain Neoplasms	1
730	2018.0	Primary Mediastinal (Thymic) Large B-cell Lymphoma	1
731	2018.0	Primary Peritoneal Cancer	1
732	2018.0	Primary Peritoneal Carcinoma	1
733	2018.0	Prolymphocytic Leukemia	1
734	2018.0	Prostate Adenocarcinoma	1
735	2018.0	Radiation Pneumonitis	1
736	2018.0	Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia	1
737	2018.0	Recurrent Childhood B-Lymphoblastic Lymphoma	1
738	2018.0	Recurrent Melanoma	1
739	2018.0	Recurrent Nasopharynx Carcinoma	1
740	2018.0	Recurrent Neuroblastoma	1
741	2018.0	Recurrent Non-small Cell Lung Cancer	1
742	2018.0	Recurrent Osteosarcoma	1
743	2018.0	Recurrent Ovarian Cancer	1
744	2018.0	Recurrent Small Cell Lung Cancer	1
745	2018.0	Refractory Acute Myeloid Leukemia	1
746	2018.0	Refractory T-Cell Lymphoma	1
747	2018.0	Relapsed Acute Myeloid Leukemia	1
748	2018.0	Relapsed Neuroblastoma	1
749	2018.0	Relapsed T-Cell Lymphoma	1
750	2018.0	Relapsed/Refractory Acute Myeloid Leukemia	1
751	2018.0	Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas	1
752	2018.0	Renal Tumors	1
753	2018.0	Resectable Pancreatic Cancer	1
754	2018.0	Resectable Pancreatic Cancers	1
755	2018.0	Sarcoma, Ewing	1
756	2018.0	Sarcoma, Myeloid	1
757	2018.0	Severe Congenital Neutropenia	1
758	2018.0	Shwachman Diamond Syndrome	1
759	2018.0	Small Cell Lung Cancer	1
760	2018.0	Solid Tumor	1
761	2018.0	Squamous Cell Carcinoma of the Head and Neck	1
762	2018.0	Stage I-III Colon Cancer	1
763	2018.0	Stage II Childhood Hodgkin Lymphoma	1
764	2018.0	Stage II Rectal Cancer	1
765	2018.0	Stage III Childhood Hodgkin Lymphoma	1
766	2018.0	Stage III Rectal Cancer	1
767	2018.0	Stage IIIA Melanoma	1
768	2018.0	Stage IIIA Non-small Cell Lung Cancer	1
769	2018.0	Stage IIIB Melanoma	1
770	2018.0	Stage IIIB Non-small Cell Lung Cancer	1
771	2018.0	Stage IIIC Melanoma	1
772	2018.0	Stage IV Breast Cancer	1
773	2018.0	Stage IV Childhood Hodgkin Lymphoma	1
774	2018.0	Stage IV Colon Cancer With Resectable Liver Metastases	1
775	2018.0	Stage IV Melanoma	1
776	2018.0	Stage IV Non-small Cell Lung Cancer	1
777	2018.0	Stage, Colon Cancer	1
778	2018.0	Stroke	1
779	2018.0	Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET)	1
780	2018.0	T-cell Adult Acute Lymphoblastic Leukemia	1
781	2018.0	TSC1	1
782	2018.0	TSC2	1
783	2018.0	Testicular Neoplasms	1
784	2018.0	Thalassemia	1
785	2018.0	Triple Negative Breast Cancer	1
786	2018.0	Tuberous Sclerosis Complex	1
787	2018.0	Tufted Angioma	1
788	2018.0	Unresectable Locally Advanced Invasive Breast Cancer	1
789	2018.0	Urothelial Cancer	1
790	2018.0	Waldenstrom Macroglobulinemia	1
791	2018.0	Waldenstrom's Macroglobulinemia	1
792	2018.0	Wiskott-Aldrich Syndrome	1
793	2019.0	Breast Cancer	14
794	2019.0	Prostate Cancer	10
795	2019.0	Neuroblastoma	7
796	2019.0	Acute Lymphoblastic Leukemia	6
797	2019.0	Leukemia	6
798	2019.0	Lymphoma	6
799	2019.0	Acute Myeloid Leukemia	4
800	2019.0	Chronic Lymphocytic Leukemia	4
801	2019.0	Sarcoma	4
802	2019.0	Acute Myeloid Leukemia (AML)	3
803	2019.0	Head and Neck Cancer	3
804	2019.0	Lymphoblastic Lymphoma	3
805	2019.0	Pancreas Cancer	3
806	2019.0	Pancreatic Cancer	3
807	2019.0	Retinoblastoma	3
808	2019.0	Rhabdomyosarcoma	3
809	2019.0	Brain Tumor, Recurrent	2
810	2019.0	Breast Neoplasms	2
811	2019.0	Burkitt's Lymphoma	2
812	2019.0	Carcinoma, Squamous Cell of Head and Neck	2
813	2019.0	Cervical Cancer	2
814	2019.0	Chronic Myelogenous Leukemia	2
815	2019.0	Colorectal Cancer	2
816	2019.0	Diffuse Large B Cell Lymphoma	2
817	2019.0	Esophageal Cancer	2
818	2019.0	Glioma	2
819	2019.0	Graft Versus Host Disease	2
820	2019.0	Hodgkin's Lymphoma	2
821	2019.0	Medulloblastoma	2
822	2019.0	Melanoma	2
823	2019.0	Metastatic Breast Cancer	2
824	2019.0	Multiple Myeloma	2
825	2019.0	Myelodysplasia	2
826	2019.0	Myelodysplastic Syndrome	2
827	2019.0	Myelodysplastic Syndromes	2
828	2019.0	Myelofibrosis	2
829	2019.0	Non-Hodgkin's Lymphoma	2
830	2019.0	Ovarian Cancer	2
831	2019.0	Recurrent Breast Cancer	2
832	2019.0	Severe Aplastic Anemia	2
833	2019.0	Squamous Cell Carcinoma	2
834	2019.0	Acute Granulocytic Leukemia	1
835	2019.0	Acute Leukemia	1
836	2019.0	Acute Leukemias	1
837	2019.0	Acute Lymphoblastic Leukemia in Complete Remission	1
838	2019.0	Acute Lymphocytic Leukemia (ALL)	1
839	2019.0	Acute Myelocytic Leukemia	1
840	2019.0	Acute Myelogenous Leukemia	1
841	2019.0	Acute Non-Lymphocytic Leukemia	1
842	2019.0	Adenocarcinoma of the Gastroesophageal Junction	1
843	2019.0	Adenocarcinoma of the Lung	1
844	2019.0	Adenocarcinoma of the Rectum	1
845	2019.0	Advanced HER2-positive Breast Cancer	1
846	2019.0	Allogeneic Transplant	1
847	2019.0	Anaplastic Astrocytoma	1
848	2019.0	Anastomotic Leak	1
849	2019.0	Atypical Teratoid/Rhabdoid Tumor (AT/RT)	1
850	2019.0	B-cell Adult Acute Lymphoblastic Leukemia	1
851	2019.0	Bladder Cancer	1
852	2019.0	Bladder Carcinoma	1
853	2019.0	Borderline Resectable Pancreatic Cancer	1
854	2019.0	Brain Metastases From HER2 and Breast Cancer	1
855	2019.0	Brain Tumor - Metastatic	1
856	2019.0	Brain and Central Nervous System Tumors	1
857	2019.0	Brainstem Glioma	1
858	2019.0	Breast Cancer Prevention	1
859	2019.0	Breast Cancer Stage IV	1
860	2019.0	CNS Tumors	1
861	2019.0	Cancer	1
862	2019.0	Cancer of Nasopharynx	1
863	2019.0	Carcinoma of Larynx	1
864	2019.0	Carcinoma of the Breast	1
865	2019.0	Carcinoma, Squamous	1
866	2019.0	Chediak Higashi Syndrome	1
867	2019.0	Cholangiocarcinoma	1
868	2019.0	Chronic Granulomatous Disease	1
869	2019.0	Colon Cancer	1
870	2019.0	Diamond Blackfan Anemia	1
871	2019.0	Diffuse Large B-Cell Lymphoma	1
872	2019.0	Diffuse Large Cell Lymphoma Relapsed/Refractory	1
873	2019.0	Ductal Carcinoma in Situ	1
874	2019.0	Dyskeratosis Congenita	1
875	2019.0	EWINGS SARCOMA	1
876	2019.0	Early Invasive Cervical Squamous Cell Carcinoma	1
877	2019.0	Early Stage Breast Cancer	1
878	2019.0	Endometrial Cancer	1
879	2019.0	Ewing's Family Tumors	1
880	2019.0	Extensive Stage Small Cell Lung Cancer	1
881	2019.0	Fallopian Tube Cancer	1
882	2019.0	Fallopian Tube Carcinoma	1
883	2019.0	Fanconi Anemia	1
884	2019.0	Fatigue Related to Cancer Treatment	1
885	2019.0	Follicular Lymphoma	1
886	2019.0	Gastric Cancer	1
887	2019.0	Gastrointestinal Stromal Tumor	1
888	2019.0	Gene Mutation	1
889	2019.0	Germ Cell Tumors	1
890	2019.0	Germline Mutation Carrier	1
891	2019.0	Glanzmann Thrombasthenia	1
892	2019.0	Glial Cell Tumors	1
893	2019.0	Glioblastoma	1
894	2019.0	Glioblastoma Multiforme	1
895	2019.0	Glioblastoma Multiforme of Brain	1
896	2019.0	Glioma - Recurrent Grade II	1
897	2019.0	Gliomatosis Cerebri	1
898	2019.0	Gliosarcoma	1
899	2019.0	HER-2 Positive Breast Cancer	1
900	2019.0	HPV Positive Oropharyngeal Squamous Cell Carcinoma	1
901	2019.0	Hematopoietic Stem Cells	1
902	2019.0	Hemophagocytic Lymphohistiocytosis	1
903	2019.0	Hepatoblastoma	1
904	2019.0	Her 2 Positive Breast Cancer	1
905	2019.0	High Risk Prostate Cancer	1
906	2019.0	Histiocytic Sarcoma (HS)	1
907	2019.0	Histiocytoses Erdheim-chester Disease	1
908	2019.0	Hodgkin Disease	1
909	2019.0	Human Epidermal Growth Factor 2 Negative Carcinoma of Breast	1
910	2019.0	Hurler Syndrome	1
911	2019.0	Hypopharyngeal Cancer	1
912	2019.0	Inflammatory Breast Cancer	1
913	2019.0	Invasive Breast Cancer	1
914	2019.0	Invasive Breast Cancer (Stage I-III)	1
915	2019.0	Kaposiform Hemangioendothelioma (KHE)	1
916	2019.0	Kasabach-Merritt Syndrome	1
917	2019.0	Langerhans Cell Histiocytosis (LCH)	1
918	2019.0	Leukemia, Acute Myelogenous	1
919	2019.0	Leukocyte Adhesion Deficiency	1
920	2019.0	Limited Stage Small Cell Lung Cancer	1
921	2019.0	Liver Cancer	1
922	2019.0	Lobular Carcinoma	1
923	2019.0	Lobular Carcinoma in Situ	1
924	2019.0	Lung Cancer	1
925	2019.0	Lymphangioleiomyomatosis	1
926	2019.0	Lymphoblastic Lymphoma in Complete Remission	1
927	2019.0	Lymphoma, B-Cell	1
928	2019.0	Lymphoplasmacytic Lymphoma	1
929	2019.0	Lynch Syndrome	1
930	2019.0	MTOR	1
931	2019.0	Malignant Gliomas	1
932	2019.0	Malignant Melanoma	1
933	2019.0	Mantle-Cell Lymphoma	1
934	2019.0	Marginal Zone B-Cell Lymphoma	1
935	2019.0	Mature B-Cell Lymphoma	1
936	2019.0	Metastatic Colorectal Cancer	1
937	2019.0	Metastatic Hormone-sensitive Prostate Cancer	1
938	2019.0	Metastatic Invasive Breast Cancer	1
939	2019.0	Metastatic Melanoma	1
940	2019.0	Metastatic Sarcoma	1
941	2019.0	Mixed Phenotype Acute Leukemia in Complete Remission	1
942	2019.0	Myelodysplastic Syndrome (MDS)	1
943	2019.0	Myeloid Hematological Malignancies	1
944	2019.0	Neuroectodermal Tumors, Primitive	1
945	2019.0	Non Small Cell Lung Cancer	1
946	2019.0	Non-Hodgkin Lymphoma	1
947	2019.0	Non-Melanoma Skin Cancers	1
948	2019.0	Non-Small Cell Lung Cancer (NSCLC)	1
949	2019.0	Nonneoplastic Condition	1
950	2019.0	Oropharyngeal Cancer	1
951	2019.0	Oropharyngeal Neoplasms	1
952	2019.0	Osteosarcoma	1
953	2019.0	Pancreatic Ductal Carcinoma	1
954	2019.0	Paraganglioma	1
955	2019.0	Pediatric Progressive Low-grade Gliomas	1
956	2019.0	Pediatric Recurrent Progressive Low-grade Gliomas	1
957	2019.0	Peutz-Jeghers Syndrome	1
958	2019.0	Pheochromocytoma	1
959	2019.0	Plasma Cell Leukemia	1
960	2019.0	Post Transplant Lymphoproliferative Disorder	1
961	2019.0	Primary Malignant Brain Neoplasms	1
962	2019.0	Primary Mediastinal (Thymic) Large B-cell Lymphoma	1
963	2019.0	Primary Peritoneal Cancer	1
964	2019.0	Primary Peritoneal Carcinoma	1
965	2019.0	Prolymphocytic Leukemia	1
966	2019.0	Prostate Adenocarcinoma	1
967	2019.0	Radiation Pneumonitis	1
968	2019.0	Rectal Cancer	1
969	2019.0	Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia	1
970	2019.0	Recurrent Childhood B-Lymphoblastic Lymphoma	1
971	2019.0	Recurrent Glioblastoma	1
972	2019.0	Recurrent Melanoma	1
973	2019.0	Recurrent Nasopharynx Carcinoma	1
974	2019.0	Recurrent Non-small Cell Lung Cancer	1
975	2019.0	Recurrent Small Cell Lung Cancer	1
976	2019.0	Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas	1
977	2019.0	Renal Tumors	1
978	2019.0	Resectable Pancreatic Cancer	1
979	2019.0	Resectable Pancreatic Cancers	1
980	2019.0	Sarcoma, Ewing	1
981	2019.0	Severe Congenital Neutropenia	1
982	2019.0	Shwachman Diamond Syndrome	1
983	2019.0	Small Cell Lung Cancer	1
984	2019.0	Small Lymphocytic Lymphoma	1
985	2019.0	Soft Tissue Sarcoma	1
986	2019.0	Stage I-III Colon Cancer	1
987	2019.0	Stage II Childhood Hodgkin Lymphoma	1
988	2019.0	Stage II Rectal Cancer	1
989	2019.0	Stage III Childhood Hodgkin Lymphoma	1
990	2019.0	Stage III Rectal Cancer	1
991	2019.0	Stage IIIA Melanoma	1
992	2019.0	Stage IIIA Non-small Cell Lung Cancer	1
993	2019.0	Stage IIIB Melanoma	1
994	2019.0	Stage IIIB Non-small Cell Lung Cancer	1
995	2019.0	Stage IIIC Melanoma	1
996	2019.0	Stage IV Childhood Hodgkin Lymphoma	1
997	2019.0	Stage IV Colon Cancer With Resectable Liver Metastases	1
998	2019.0	Stage IV Melanoma	1
999	2019.0	Stage IV Non-small Cell Lung Cancer	1
1000	2019.0	Stage, Colon Cancer	1
1001	2019.0	Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET)	1
1002	2019.0	T-cell Adult Acute Lymphoblastic Leukemia	1
1003	2019.0	TSC1	1
1004	2019.0	TSC2	1
1005	2019.0	Thalassemia	1
1006	2019.0	Triple Negative Breast Cancer	1
1007	2019.0	Tuberous Sclerosis Complex	1
1008	2019.0	Tufted Angioma	1
1009	2019.0	Unresectable Locally Advanced Invasive Breast Cancer	1
1010	2019.0	Urothelial Cancer	1
1011	2019.0	Waldenstrom's Macroglobulinemia	1
1012	2019.0	Wilms Tumor	1
1013	2019.0	Wiskott-Aldrich Syndrome	1
1014	2020.0	Breast Cancer	9
1015	2020.0	Prostate Cancer	6
1016	2020.0	Leukemia	5
1017	2020.0	Neuroblastoma	5
1018	2020.0	Acute Myeloid Leukemia	4
1019	2020.0	Chronic Lymphocytic Leukemia	4
1020	2020.0	Acute Myeloid Leukemia (AML)	3
1021	2020.0	Lymphoblastic Lymphoma	3
1022	2020.0	Lymphoma	3
1023	2020.0	Pancreas Cancer	3
1024	2020.0	Sarcoma	3
1025	2020.0	Brain Tumor, Recurrent	2
1026	2020.0	Burkitt's Lymphoma	2
1027	2020.0	Carcinoma, Squamous Cell of Head and Neck	2
1028	2020.0	Cervical Cancer	2
1029	2020.0	Chronic Myelogenous Leukemia	2
1030	2020.0	Diffuse Large B Cell Lymphoma	2
1031	2020.0	Graft Versus Host Disease	2
1032	2020.0	Head and Neck Cancer	2
1033	2020.0	Melanoma	2
1034	2020.0	Multiple Myeloma	2
1035	2020.0	Myelodysplasia	2
1036	2020.0	Myelodysplastic Syndromes	2
1037	2020.0	Ovarian Cancer	2
1038	2020.0	Pancreatic Cancer	2
1039	2020.0	Retinoblastoma	2
1040	2020.0	Rhabdomyosarcoma	2
1041	2020.0	Acute Granulocytic Leukemia	1
1042	2020.0	Acute Leukemia	1
1043	2020.0	Acute Leukemias	1
1044	2020.0	Acute Lymphoblastic Leukemia	1
1045	2020.0	Acute Lymphoblastic Leukemia in Complete Remission	1
1046	2020.0	Acute Lymphocytic Leukemia (ALL)	1
1047	2020.0	Acute Myelocytic Leukemia	1
1048	2020.0	Acute Myelogenous Leukemia	1
1049	2020.0	Acute Non-Lymphocytic Leukemia	1
1050	2020.0	Anastomotic Leak	1
1051	2020.0	B-cell Adult Acute Lymphoblastic Leukemia	1
1052	2020.0	Bladder Carcinoma	1
1053	2020.0	Brain Tumor - Metastatic	1
1054	2020.0	Brain and Central Nervous System Tumors	1
1055	2020.0	Breast Cancer Prevention	1
1056	2020.0	Breast Cancer Stage IV	1
1057	2020.0	Cancer	1
1058	2020.0	Cancer of Nasopharynx	1
1059	2020.0	Carcinoma of Larynx	1
1060	2020.0	Carcinoma of the Breast	1
1061	2020.0	Carcinoma, Squamous	1
1062	2020.0	Chediak Higashi Syndrome	1
1063	2020.0	Cholangiocarcinoma	1
1064	2020.0	Chronic Granulomatous Disease	1
1065	2020.0	Colorectal Cancer	1
1066	2020.0	Diamond Blackfan Anemia	1
1067	2020.0	Ductal Carcinoma in Situ	1
1068	2020.0	Dyskeratosis Congenita	1
1069	2020.0	EWINGS SARCOMA	1
1070	2020.0	Early Invasive Cervical Squamous Cell Carcinoma	1
1071	2020.0	Early Stage Breast Cancer	1
1072	2020.0	Esophageal Cancer	1
1073	2020.0	Fallopian Tube Cancer	1
1074	2020.0	Fallopian Tube Carcinoma	1
1075	2020.0	Fanconi Anemia	1
1076	2020.0	Fatigue Related to Cancer Treatment	1
1077	2020.0	Follicular Lymphoma	1
1078	2020.0	Gastrointestinal Stromal Tumor	1
1079	2020.0	Gene Mutation	1
1080	2020.0	Germline Mutation Carrier	1
1081	2020.0	Glanzmann Thrombasthenia	1
1082	2020.0	Glioma	1
1083	2020.0	HER-2 Positive Breast Cancer	1
1084	2020.0	HPV Positive Oropharyngeal Squamous Cell Carcinoma	1
1085	2020.0	Hematopoietic Stem Cells	1
1086	2020.0	Hemophagocytic Lymphohistiocytosis	1
1087	2020.0	High Risk Prostate Cancer	1
1088	2020.0	Histiocytic Sarcoma (HS)	1
1089	2020.0	Histiocytoses Erdheim-chester Disease	1
1090	2020.0	Hodgkin's Lymphoma	1
1091	2020.0	Human Epidermal Growth Factor 2 Negative Carcinoma of Breast	1
1092	2020.0	Hurler Syndrome	1
1093	2020.0	Hypopharyngeal Cancer	1
1094	2020.0	Inflammatory Breast Cancer	1
1095	2020.0	Invasive Breast Cancer (Stage I-III)	1
1096	2020.0	Langerhans Cell Histiocytosis (LCH)	1
1097	2020.0	Leukemia, Acute Myelogenous	1
1098	2020.0	Leukocyte Adhesion Deficiency	1
1099	2020.0	Liver Cancer	1
1100	2020.0	Lobular Carcinoma	1
1101	2020.0	Lobular Carcinoma in Situ	1
1102	2020.0	Lung Cancer	1
1103	2020.0	Lymphangioleiomyomatosis	1
1104	2020.0	Lymphoblastic Lymphoma in Complete Remission	1
1105	2020.0	Lymphoma, B-Cell	1
1106	2020.0	Lymphoplasmacytic Lymphoma	1
1107	2020.0	Lynch Syndrome	1
1108	2020.0	MTOR	1
1109	2020.0	Mantle-Cell Lymphoma	1
1110	2020.0	Marginal Zone B-Cell Lymphoma	1
1111	2020.0	Mature B-Cell Lymphoma	1
1112	2020.0	Medulloblastoma	1
1113	2020.0	Metastatic Breast Cancer	1
1114	2020.0	Metastatic Colorectal Cancer	1
1115	2020.0	Metastatic Hormone-sensitive Prostate Cancer	1
1116	2020.0	Metastatic Invasive Breast Cancer	1
1117	2020.0	Metastatic Sarcoma	1
1118	2020.0	Mixed Phenotype Acute Leukemia in Complete Remission	1
1119	2020.0	Myelodysplastic Syndrome	1
1120	2020.0	Myelodysplastic Syndrome (MDS)	1
1121	2020.0	Myelofibrosis	1
1122	2020.0	Myeloid Hematological Malignancies	1
1123	2020.0	Neuroectodermal Tumors, Primitive	1
1124	2020.0	Non Small Cell Lung Cancer	1
1125	2020.0	Non-Hodgkin Lymphoma	1
1126	2020.0	Non-Hodgkin's Lymphoma	1
1127	2020.0	Non-Melanoma Skin Cancers	1
1128	2020.0	Non-Small Cell Lung Cancer (NSCLC)	1
1129	2020.0	Nonneoplastic Condition	1
1130	2020.0	Oropharyngeal Cancer	1
1131	2020.0	Oropharyngeal Neoplasms	1
1132	2020.0	Osteosarcoma	1
1133	2020.0	Pancreatic Ductal Carcinoma	1
1134	2020.0	Paraganglioma	1
1135	2020.0	Pediatric Progressive Low-grade Gliomas	1
1136	2020.0	Pediatric Recurrent Progressive Low-grade Gliomas	1
1137	2020.0	Peutz-Jeghers Syndrome	1
1138	2020.0	Pheochromocytoma	1
1139	2020.0	Plasma Cell Leukemia	1
1140	2020.0	Post Transplant Lymphoproliferative Disorder	1
1141	2020.0	Primary Mediastinal (Thymic) Large B-cell Lymphoma	1
1142	2020.0	Primary Peritoneal Cancer	1
1143	2020.0	Primary Peritoneal Carcinoma	1
1144	2020.0	Prolymphocytic Leukemia	1
1145	2020.0	Prostate Adenocarcinoma	1
1146	2020.0	Radiation Pneumonitis	1
1147	2020.0	Rectal Cancer	1
1148	2020.0	Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia	1
1149	2020.0	Recurrent Breast Cancer	1
1150	2020.0	Recurrent Childhood B-Lymphoblastic Lymphoma	1
1151	2020.0	Recurrent Melanoma	1
1152	2020.0	Recurrent Nasopharynx Carcinoma	1
1153	2020.0	Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas	1
1154	2020.0	Resectable Pancreatic Cancer	1
1155	2020.0	Sarcoma, Ewing	1
1156	2020.0	Severe Aplastic Anemia	1
1157	2020.0	Severe Congenital Neutropenia	1
1158	2020.0	Shwachman Diamond Syndrome	1
1159	2020.0	Small Cell Lung Cancer	1
1160	2020.0	Small Lymphocytic Lymphoma	1
1161	2020.0	Squamous Cell Carcinoma	1
1162	2020.0	Stage I-III Colon Cancer	1
1163	2020.0	Stage II Childhood Hodgkin Lymphoma	1
1164	2020.0	Stage III Childhood Hodgkin Lymphoma	1
1165	2020.0	Stage IIIA Melanoma	1
1166	2020.0	Stage IIIB Melanoma	1
1167	2020.0	Stage IIIC Melanoma	1
1168	2020.0	Stage IV Childhood Hodgkin Lymphoma	1
1169	2020.0	Stage IV Colon Cancer With Resectable Liver Metastases	1
1170	2020.0	Stage IV Melanoma	1
1171	2020.0	Stage, Colon Cancer	1
1172	2020.0	T-cell Adult Acute Lymphoblastic Leukemia	1
1173	2020.0	TSC1	1
1174	2020.0	TSC2	1
1175	2020.0	Thalassemia	1
1176	2020.0	Triple Negative Breast Cancer	1
1177	2020.0	Tuberous Sclerosis Complex	1
1178	2020.0	Unresectable Locally Advanced Invasive Breast Cancer	1
1179	2020.0	Waldenstrom's Macroglobulinemia	1
1180	2020.0	Wilms Tumor	1
1181	2020.0	Wiskott-Aldrich Syndrome	1
1182	2021.0	Breast Cancer	6
1183	2021.0	Neuroblastoma	5
1184	2021.0	Prostate Cancer	4
1185	2021.0	Acute Myeloid Leukemia	3
1186	2021.0	Acute Myeloid Leukemia (AML)	3
1187	2021.0	Chronic Lymphocytic Leukemia	3
1188	2021.0	Brain Tumor, Recurrent	2
1189	2021.0	Diffuse Large B Cell Lymphoma	2
1190	2021.0	Lymphoblastic Lymphoma	2
1191	2021.0	Multiple Myeloma	2
1192	2021.0	Myelodysplasia	2
1193	2021.0	Pancreas Cancer	2
1194	2021.0	Acute Granulocytic Leukemia	1
1195	2021.0	Acute Leukemia	1
1196	2021.0	Acute Lymphoblastic Leukemia in Complete Remission	1
1197	2021.0	Acute Lymphocytic Leukemia (ALL)	1
1198	2021.0	Acute Myelocytic Leukemia	1
1199	2021.0	Acute Myelogenous Leukemia	1
1200	2021.0	Acute Non-Lymphocytic Leukemia	1
1201	2021.0	Bladder Carcinoma	1
1202	2021.0	Brain Tumor - Metastatic	1
1203	2021.0	Brain and Central Nervous System Tumors	1
1204	2021.0	Breast Cancer Stage IV	1
1205	2021.0	Burkitt's Lymphoma	1
1206	2021.0	Carcinoma of the Breast	1
1207	2021.0	Carcinoma, Squamous	1
1208	2021.0	Cervical Cancer	1
1209	2021.0	Cholangiocarcinoma	1
1210	2021.0	Chronic Myelogenous Leukemia	1
1211	2021.0	Colorectal Cancer	1
1212	2021.0	Ductal Carcinoma in Situ	1
1213	2021.0	Early Stage Breast Cancer	1
1214	2021.0	Esophageal Cancer	1
1215	2021.0	Fallopian Tube Cancer	1
1216	2021.0	Fatigue Related to Cancer Treatment	1
1217	2021.0	Follicular Lymphoma	1
1218	2021.0	Gene Mutation	1
1219	2021.0	Germline Mutation Carrier	1
1220	2021.0	HER-2 Positive Breast Cancer	1
1221	2021.0	Head and Neck Cancer	1
1222	2021.0	Hematopoietic Stem Cells	1
1223	2021.0	High Risk Prostate Cancer	1
1224	2021.0	Histiocytic Sarcoma (HS)	1
1225	2021.0	Histiocytoses Erdheim-chester Disease	1
1226	2021.0	Hodgkin's Lymphoma	1
1227	2021.0	Human Epidermal Growth Factor 2 Negative Carcinoma of Breast	1
1228	2021.0	Inflammatory Breast Cancer	1
1229	2021.0	Invasive Breast Cancer (Stage I-III)	1
1230	2021.0	Langerhans Cell Histiocytosis (LCH)	1
1231	2021.0	Leukemia	1
1232	2021.0	Leukemia, Acute Myelogenous	1
1233	2021.0	Lobular Carcinoma	1
1234	2021.0	Lobular Carcinoma in Situ	1
1235	2021.0	Lymphoblastic Lymphoma in Complete Remission	1
1236	2021.0	Lymphoma	1
1237	2021.0	Lymphoma, B-Cell	1
1238	2021.0	Lymphoplasmacytic Lymphoma	1
1239	2021.0	Lynch Syndrome	1
1240	2021.0	MTOR	1
1241	2021.0	Mantle-Cell Lymphoma	1
1242	2021.0	Marginal Zone B-Cell Lymphoma	1
1243	2021.0	Mature B-Cell Lymphoma	1
1244	2021.0	Medulloblastoma	1
1245	2021.0	Metastatic Hormone-sensitive Prostate Cancer	1
1246	2021.0	Metastatic Invasive Breast Cancer	1
1247	2021.0	Metastatic Sarcoma	1
1248	2021.0	Mixed Phenotype Acute Leukemia in Complete Remission	1
1249	2021.0	Myelodysplastic Syndrome (MDS)	1
1250	2021.0	Myelofibrosis	1
1251	2021.0	Myeloid Hematological Malignancies	1
1252	2021.0	Non-Hodgkin Lymphoma	1
1253	2021.0	Non-Hodgkin's Lymphoma	1
1254	2021.0	Non-Small Cell Lung Cancer (NSCLC)	1
1255	2021.0	Oropharyngeal Cancer	1
1256	2021.0	Oropharyngeal Neoplasms	1
1257	2021.0	Ovarian Cancer	1
1258	2021.0	Pancreatic Cancer	1
1259	2021.0	Pancreatic Ductal Carcinoma	1
1260	2021.0	Paraganglioma	1
1261	2021.0	Pediatric Progressive Low-grade Gliomas	1
1262	2021.0	Pediatric Recurrent Progressive Low-grade Gliomas	1
1263	2021.0	Peutz-Jeghers Syndrome	1
1264	2021.0	Pheochromocytoma	1
1265	2021.0	Plasma Cell Leukemia	1
1266	2021.0	Post Transplant Lymphoproliferative Disorder	1
1267	2021.0	Primary Mediastinal (Thymic) Large B-cell Lymphoma	1
1268	2021.0	Primary Peritoneal Cancer	1
1269	2021.0	Prolymphocytic Leukemia	1
1270	2021.0	Prostate Adenocarcinoma	1
1271	2021.0	Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia	1
1272	2021.0	Recurrent Childhood B-Lymphoblastic Lymphoma	1
1273	2021.0	Recurrent Nasopharynx Carcinoma	1
1274	2021.0	Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas	1
1275	2021.0	Resectable Pancreatic Cancer	1
1276	2021.0	Retinoblastoma	1
1277	2021.0	Rhabdomyosarcoma	1
1278	2021.0	Sarcoma	1
1279	2021.0	Small Cell Lung Cancer	1
1280	2021.0	Small Lymphocytic Lymphoma	1
1281	2021.0	Squamous Cell Carcinoma	1
1282	2021.0	Stage II Childhood Hodgkin Lymphoma	1
1283	2021.0	Stage III Childhood Hodgkin Lymphoma	1
1284	2021.0	Stage IV Childhood Hodgkin Lymphoma	1
1285	2021.0	TSC1	1
1286	2021.0	TSC2	1
1287	2021.0	Triple Negative Breast Cancer	1
1288	2021.0	Tuberous Sclerosis Complex	1
1289	2021.0	Unresectable Locally Advanced Invasive Breast Cancer	1
1290	2021.0	Waldenstrom's Macroglobulinemia	1
1291	2022.0	Neuroblastoma	5
1292	2022.0	Breast Cancer	4
1293	2022.0	Acute Myeloid Leukemia (AML)	3
1294	2022.0	Prostate Cancer	3
1295	2022.0	Acute Myeloid Leukemia	2
1296	2022.0	Diffuse Large B Cell Lymphoma	2
1297	2022.0	Lymphoblastic Lymphoma	2
1298	2022.0	Pancreas Cancer	2
1299	2022.0	Acute Granulocytic Leukemia	1
1300	2022.0	Acute Lymphocytic Leukemia (ALL)	1
1301	2022.0	Acute Myelocytic Leukemia	1
1302	2022.0	Acute Myelogenous Leukemia	1
1303	2022.0	Acute Non-Lymphocytic Leukemia	1
1304	2022.0	Brain Tumor - Metastatic	1
1305	2022.0	Brain and Central Nervous System Tumors	1
1306	2022.0	Breast Cancer Stage IV	1
1307	2022.0	Burkitt's Lymphoma	1
1308	2022.0	Carcinoma, Squamous	1
1309	2022.0	Cholangiocarcinoma	1
1310	2022.0	Chronic Lymphocytic Leukemia	1
1311	2022.0	Chronic Myelogenous Leukemia	1
1312	2022.0	Colorectal Cancer	1
1313	2022.0	Ductal Carcinoma in Situ	1
1314	2022.0	Early Stage Breast Cancer	1
1315	2022.0	Fallopian Tube Cancer	1
1316	2022.0	Fatigue Related to Cancer Treatment	1
1317	2022.0	Follicular Lymphoma	1
1318	2022.0	Gene Mutation	1
1319	2022.0	Germline Mutation Carrier	1
1320	2022.0	High Risk Prostate Cancer	1
1321	2022.0	Histiocytic Sarcoma (HS)	1
1322	2022.0	Histiocytoses Erdheim-chester Disease	1
1323	2022.0	Human Epidermal Growth Factor 2 Negative Carcinoma of Breast	1
1324	2022.0	Inflammatory Breast Cancer	1
1325	2022.0	Invasive Breast Cancer (Stage I-III)	1
1326	2022.0	Langerhans Cell Histiocytosis (LCH)	1
1327	2022.0	Leukemia	1
1328	2022.0	Leukemia, Acute Myelogenous	1
1329	2022.0	Lobular Carcinoma	1
1330	2022.0	Lobular Carcinoma in Situ	1
1331	2022.0	Lymphoma	1
1332	2022.0	Lymphoplasmacytic Lymphoma	1
1333	2022.0	Lynch Syndrome	1
1334	2022.0	MTOR	1
1335	2022.0	Mantle-Cell Lymphoma	1
1336	2022.0	Marginal Zone B-Cell Lymphoma	1
1337	2022.0	Mature B-Cell Lymphoma	1
1338	2022.0	Medulloblastoma	1
1339	2022.0	Metastatic Hormone-sensitive Prostate Cancer	1
1340	2022.0	Metastatic Invasive Breast Cancer	1
1341	2022.0	Metastatic Sarcoma	1
1342	2022.0	Multiple Myeloma	1
1343	2022.0	Myelodysplasia	1
1344	2022.0	Myelodysplastic Syndrome (MDS)	1
1345	2022.0	Myelofibrosis	1
1346	2022.0	Myeloid Hematological Malignancies	1
1347	2022.0	Non-Hodgkin Lymphoma	1
1348	2022.0	Non-Small Cell Lung Cancer (NSCLC)	1
1349	2022.0	Oropharyngeal Cancer	1
1350	2022.0	Oropharyngeal Neoplasms	1
1351	2022.0	Ovarian Cancer	1
1352	2022.0	Pancreatic Cancer	1
1353	2022.0	Pancreatic Ductal Carcinoma	1
1354	2022.0	Pediatric Progressive Low-grade Gliomas	1
1355	2022.0	Pediatric Recurrent Progressive Low-grade Gliomas	1
1356	2022.0	Peutz-Jeghers Syndrome	1
1357	2022.0	Plasma Cell Leukemia	1
1358	2022.0	Post Transplant Lymphoproliferative Disorder	1
1359	2022.0	Primary Mediastinal (Thymic) Large B-cell Lymphoma	1
1360	2022.0	Primary Peritoneal Cancer	1
1361	2022.0	Prolymphocytic Leukemia	1
1362	2022.0	Prostate Adenocarcinoma	1
1363	2022.0	Recurrent Nasopharynx Carcinoma	1
1364	2022.0	Resectable Pancreatic Cancer	1
1365	2022.0	Retinoblastoma	1
1366	2022.0	Sarcoma	1
1367	2022.0	Small Cell Lung Cancer	1
1368	2022.0	Small Lymphocytic Lymphoma	1
1369	2022.0	Squamous Cell Carcinoma	1
1370	2022.0	Stage II Childhood Hodgkin Lymphoma	1
1371	2022.0	Stage III Childhood Hodgkin Lymphoma	1
1372	2022.0	Stage IV Childhood Hodgkin Lymphoma	1
1373	2022.0	TSC1	1
1374	2022.0	TSC2	1
1375	2022.0	Tuberous Sclerosis Complex	1
1376	2022.0	Unresectable Locally Advanced Invasive Breast Cancer	1
1377	2023.0	Neuroblastoma	5
1378	2023.0	Breast Cancer	3
1379	2023.0	Acute Myeloid Leukemia (AML)	2
1380	2023.0	Diffuse Large B Cell Lymphoma	2
1381	2023.0	Lymphoblastic Lymphoma	2
1382	2023.0	Pancreas Cancer	2
1383	2023.0	Acute Lymphocytic Leukemia (ALL)	1
1384	2023.0	Acute Myeloid Leukemia	1
1385	2023.0	Brain and Central Nervous System Tumors	1
1386	2023.0	Burkitt's Lymphoma	1
1387	2023.0	Carcinoma, Squamous	1
1388	2023.0	Chronic Lymphocytic Leukemia	1
1389	2023.0	Chronic Myelogenous Leukemia	1
1390	2023.0	Colorectal Cancer	1
1391	2023.0	Early Stage Breast Cancer	1
1392	2023.0	Follicular Lymphoma	1
1393	2023.0	Gene Mutation	1
1394	2023.0	Germline Mutation Carrier	1
1395	2023.0	Human Epidermal Growth Factor 2 Negative Carcinoma of Breast	1
1396	2023.0	Inflammatory Breast Cancer	1
1397	2023.0	Leukemia	1
1398	2023.0	Leukemia, Acute Myelogenous	1
1399	2023.0	Lymphoma	1
1400	2023.0	Lymphoplasmacytic Lymphoma	1
1401	2023.0	Lynch Syndrome	1
1402	2023.0	Mantle-Cell Lymphoma	1
1403	2023.0	Marginal Zone B-Cell Lymphoma	1
1404	2023.0	Medulloblastoma	1
1405	2023.0	Multiple Myeloma	1
1406	2023.0	Myelodysplasia	1
1407	2023.0	Myelodysplastic Syndrome (MDS)	1
1408	2023.0	Myelofibrosis	1
1409	2023.0	Myeloid Hematological Malignancies	1
1410	2023.0	Non-Hodgkin Lymphoma	1
1411	2023.0	Oropharyngeal Cancer	1
1412	2023.0	Oropharyngeal Neoplasms	1
1413	2023.0	Pancreatic Cancer	1
1414	2023.0	Peutz-Jeghers Syndrome	1
1415	2023.0	Plasma Cell Leukemia	1
1416	2023.0	Post Transplant Lymphoproliferative Disorder	1
1417	2023.0	Primary Mediastinal (Thymic) Large B-cell Lymphoma	1
1418	2023.0	Prolymphocytic Leukemia	1
1419	2023.0	Prostate Cancer	1
1420	2023.0	Sarcoma	1
1421	2023.0	Small Lymphocytic Lymphoma	1
1422	2023.0	Squamous Cell Carcinoma	1
1423	2023.0	Stage II Childhood Hodgkin Lymphoma	1
1424	2023.0	Stage III Childhood Hodgkin Lymphoma	1
1425	2023.0	Stage IV Childhood Hodgkin Lymphoma	1
1426	2024.0	Neuroblastoma	4
1427	2024.0	Acute Myeloid Leukemia	1
1428	2024.0	Breast Cancer	1
1429	2024.0	Colorectal Cancer	1
1430	2024.0	Diffuse Large B Cell Lymphoma	1
1431	2024.0	Leukemia	1
1432	2024.0	Lymphoblastic Lymphoma	1
1433	2024.0	Medulloblastoma	1
1434	2024.0	Myeloid Hematological Malignancies	1
1435	2024.0	Pancreas Cancer	1
1436	2024.0	Pancreatic Cancer	1
1437	2024.0	Post Transplant Lymphoproliferative Disorder	1
1438	2024.0	Primary Mediastinal (Thymic) Large B-cell Lymphoma	1
1439	2024.0	Prostate Cancer	1
1440	2024.0	Sarcoma	1
1441	2024.0	Stage II Childhood Hodgkin Lymphoma	1
1442	2024.0	Stage III Childhood Hodgkin Lymphoma	1
1443	2024.0	Stage IV Childhood Hodgkin Lymphoma	1
1444	2025.0	Neuroblastoma	3
1445	2025.0	Breast Cancer	1
1446	2025.0	Colorectal Cancer	1
1447	2025.0	Diffuse Large B Cell Lymphoma	1
1448	2025.0	Leukemia	1
1449	2025.0	Lymphoblastic Lymphoma	1
1450	2025.0	Medulloblastoma	1
1451	2025.0	Myeloid Hematological Malignancies	1
1452	2025.0	Post Transplant Lymphoproliferative Disorder	1
1453	2025.0	Primary Mediastinal (Thymic) Large B-cell Lymphoma	1
1454	2025.0	Prostate Cancer	1
1455	2025.0	Sarcoma	1
1456	2025.0	Stage II Childhood Hodgkin Lymphoma	1
1457	2025.0	Stage III Childhood Hodgkin Lymphoma	1
1458	2025.0	Stage IV Childhood Hodgkin Lymphoma	1
1459	2026.0	Neuroblastoma	3
1460	2026.0	Breast Cancer	1
1461	2026.0	Colorectal Cancer	1
1462	2026.0	Diffuse Large B Cell Lymphoma	1
1463	2026.0	Leukemia	1
1464	2026.0	Lymphoblastic Lymphoma	1
1465	2026.0	Medulloblastoma	1
1466	2026.0	Myeloid Hematological Malignancies	1
1467	2026.0	Post Transplant Lymphoproliferative Disorder	1
1468	2026.0	Primary Mediastinal (Thymic) Large B-cell Lymphoma	1
1469	2026.0	Prostate Cancer	1
1470	2026.0	Sarcoma	1
1471	2027.0	Neuroblastoma	2
1472	2027.0	Breast Cancer	1
1473	2027.0	Colorectal Cancer	1
1474	2027.0	Leukemia	1
1475	2027.0	Lymphoblastic Lymphoma	1
1476	2027.0	Myeloid Hematological Malignancies	1
1477	2027.0	Prostate Cancer	1
1478	2027.0	Sarcoma	1
1479	2028.0	Neuroblastoma	2
1480	2028.0	Breast Cancer	1
1481	2028.0	Colorectal Cancer	1
1482	2028.0	Leukemia	1
1483	2028.0	Prostate Cancer	1
1484	2028.0	Sarcoma	1
1485	2029.0	Neuroblastoma	2
1486	2029.0	Breast Cancer	1
1487	2029.0	Leukemia	1
1488	2029.0	Prostate Cancer	1
1489	2029.0	Sarcoma	1
1490	2030.0	Neuroblastoma	2
1491	2030.0	Breast Cancer	1
1492	2030.0	Leukemia	1
1493	2030.0	Prostate Cancer	1
1494	2030.0	Sarcoma	1
1495	2031.0	Leukemia	1
1496	2031.0	Prostate Cancer	1
1497	2032.0	Leukemia	1
1498	2032.0	Prostate Cancer	1
1499	2033.0	Leukemia	1
1500	2033.0	Prostate Cancer	1
1501	2034.0	Prostate Cancer	1
1502	2035.0	Prostate Cancer	1
